Vertex Pharmaceuticals (VRTX)
502.14
+13.85 (2.84%)
Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and commercializing innovative therapies to treat serious diseases
With an emphasis on cystic fibrosis, Vertex has pioneered groundbreaking treatments that significantly improve the lives of patients with this genetic disorder. In addition to its work in cystic fibrosis, the company is exploring potential therapies for other rare diseases, including pain management and beta-thalassemia. Vertex is dedicated to advancing scientific research and collaborating with the global medical community to bring new solutions to unmet medical needs.
| Previous Close | 488.29 |
|---|---|
| Open | 483.39 |
| Bid | 501.74 |
| Ask | 502.36 |
| Day's Range | 480.38 - 502.90 |
| 52 Week Range | 377.85 - 519.88 |
| Volume | 674,056 |
| Market Cap | 130.27B |
| PE Ratio (TTM) | -231.40 |
| EPS (TTM) | -2.2 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,345,368 |
